Patents by Inventor Sonali Ankush SAWANT

Sonali Ankush SAWANT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • A Point of Care Device, Method and Kit Involving Club Cell Protein 16 as a Marker for Silicosis
    Publication number: 20230077769
    Abstract: The present invention provides a device and method based on lateral flow immunoassay for CC16 semi-quantification in serum sample. A novel membrane based semi quantitative detection of physiological/pathological levels of CC16 in the serum has been provided. The device of the present invention provides affordable and easy to use strip-based screening approach for early detection of silicosis using CC16 as a biomarker.
    Type: Application
    Filed: March 31, 2021
    Publication date: March 16, 2023
    Inventors: Shyam Sundar NANDI, Upendra P. LAMBE, Kamlesh SARKAR, Jagadish Mohan DESHPANDE, Sonali Ankush SAWANT
  • POLIOVIRUS RECEPTOR (PVR/CD155) KNOCKOUT CELLS DERIVED FROM RD (HUMAN RHABDOMYOSARCOMA) CELL LINE BY CRISPR
    Publication number: 20220127643
    Abstract: A modified polio virus receptor (PVR/CD155) gene including one or more mutations in exons selected from exons 2, 3 and 4 of poliovirus receptor (PVR/CD155) gene having SEQ ID No.1. More specifically, cell lines including the modified gene and method of producing the same using clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein 9 (CRISPR-Cas9) system. The cell line is refractory (non-permissive) to poliovirus and susceptible to most Enteroviruses and many other human viruses. Further, the cell line can be applied in the fields of research, diagnostic and therapy.
    Type: Application
    Filed: September 13, 2019
    Publication date: April 28, 2022
    Applicant: INDIAN COUNCIL OF MEDICAL RESEARCH
    Inventors: S. S. NANDI, Sonali Ankush SAWANT, Jagdish Mohan DESHPANDE